PAVE (Parallactic Visual-Field Enhancement) System for Treatment of Chronic Visual Field Loss Due to Stroke, Traumatic Brain Injury, or Brain Surgery

Recruiting

PAVE SystemPAVE (Parallactic Visual-Field Enhancement) System for Treatment of Chronic Visual Field Loss Due to Stroke, Traumatic Brain Injury, or Brain Surgery

Sponsor:

NeuroAEye LLC

Code:

NCT07185971

Conditions

Homonymous Hemianopsia

Homonymous Quadrantanopia

Eligibility Criteria

Sex: All

Age: 21 - 70+

Healthy Volunteers: Not accepted

Interventions

PAVE (Parallactic Visual-Field Enhancement) treatment using a virtual reality head mounted display

PAVE Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-15. This information was provided to ClinicalTrials.gov by NeuroAEye LLC on 2025-11-17.